Taming hormones with food: physician resolves infertility, diabetes, & other conditions
(Physicians Committee for Responsible Medicine) Nutrition researcher and New York Times bestselling author Neal Barnard, MD, demonstrates how foods affect our hormones--and our health--in his new book, Your Body in Balance. Dr. Barnard shares the science behind how common conditions--like infertility, weight gain, menopausal symptoms, breast and prostate cancers, thyroid problems, and acne--are fueled by hormones that are hidden in or influenced by the foods we eat. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 13, 2020 Category: Biology Source Type: news

Thyroid cancer, genetic variations, cell phones linked in YSPH study
(Yale School of Public Health) Radiation from cell phones is associated with higher rates of thyroid cancer among people with genetic variations in specific genes, a new study led by the Yale School of Public Health finds. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2020 Category: Cancer & Oncology Source Type: news

Chemical found in drinking water linked to tooth decay in children
IMAGE: Being exposed to PFAS--a class of chemicals found in drinking water--has been linked to higher rates of cancer, heart disease, thyroid dysfunction and other conditions. WVU School of Dentistry researchers...viewmore Credit: Aira Burkhart/West Virginia University Children with higher concentrations of a certain chemical in their blood are more likely to get cavities, according to a new study byWest Virginia UniversitySchool of Dentistry researchers. Manufactured chemical g roups called perfluoroalkyl and polyfluoroalkyl substances are universal as a result of extensive manufacturing and use. Although manuf...
Source: Dental Technology Blog - February 11, 2020 Category: Dentistry Source Type: news

New NICE guidelines for thyroid disease
NICE have recently published new guidelines on thyroid disease assessment and management. Thyroid disease, comprising thyroid dysfunction and enlargement, is common and often identified in primary care. Conditions causing thyroid dysfunction can be broadly divided into those that result in thyroid gland underactivity (overt and subclinical hypothyroidism) or overactivity (thyrotoxicosis). Hypothyroidism is usually managed by general practitioners. Read thesummary article published inThe BMJ for the most recent recommendations from NICE. (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 10, 2020 Category: Endocrinology Source Type: news

Summary of NICE thyroid disease guidelines
Get quick and easy access to key recommendations from the NICE guideline,Thyroid disease: assessment and management, inThe BMJ summary article.Guideline recommendations are based on systematic reviews of best available clinical evidence and cost effectiveness. (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 10, 2020 Category: Endocrinology Source Type: news

Should I have kept my cancer?
Producer Lise Hosein tells her story of being diagnosed with papillary thyroid cancer, and why she wishes she didn't have surgery to remove her thyroid glands. (Source: CBC | Health)
Source: CBC | Health - February 7, 2020 Category: Consumer Health News Tags: Radio/White Coat, Black Art Source Type: news

Structure of thyroglobulin revealed
According to a study published inNature, the structure of thyroid hormone precursor, thyroglobulin, has been determined and sheds light on the biosynthesis of thyroid hormones.Nature (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 6, 2020 Category: Endocrinology Source Type: news

Frozen Section of Thyroid Nodules in Follicular Neoplasm Frozen Section of Thyroid Nodules in Follicular Neoplasm
Controversy remains surrounding the utility of intraoperative frozen sections as a diagnostic tool in patients with follicular neoplasm. Are they sufficiently sensitive and specific?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 4, 2020 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

One Brave Mom-Entrepreneur Sets Out To Solve The Thyroid Care Crisis
January is #ThyroidAwarenessMonth and this mom-entrepeneur and cofounder of Paloma Health is helping to raise awareness and innovate care for hypothyroidism. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 1, 2020 Category: Pharmaceuticals Authors: Anuja Khemka, Contributor Source Type: news

Drug Trial Snapshot: TEPEZZA
TEPEZZA is a drug for the treatment of thyroid eye disease. Thyroid eye disease is a rare, autoimmune disease characterized by proptosis (a condition where the eyes are pushed forward and bulge outward) leading to eye pain, double vision and difficulty closing the eyelid. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 29, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application
INDIANAPOLIS, Jan. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for selpercatinib (L... Biopharmaceuticals, Oncology, FDA Eli Lilly, selpercatinib, RET-mutant, thyroid cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 29, 2020 Category: Pharmaceuticals Source Type: news

Eko ’s New Algorithm Helps Digital Stethoscope Give Insight on Heart Conditions
Eko has won FDA clearance for a suite of algorithms that will allow its digital stethoscope to more accurately screen for heart conditions that include heart murmurs and atrial fibrillation (AFib) during routine physical exams. The San Francisco, CA-based company Eko’s AI identifies heart murmurs with 87% sensitivity and 87% specificity. The company said in comparison, a recent study revealed that using traditional stethoscopes, primary care physicians had a sensitivity of 43% and a specificity of 69% for detecting significant valvular heart disease, which affects more than five million Americans. The AI ...
Source: MDDI - January 29, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Digital Health Source Type: news

New guidelines will improve treatment for patients with hyperthyroidism
(University of Birmingham) Radioactive iodine is to be recommended as the frontline treatment for patients with thyroid gland overactivity caused by conditions such as Graves' disease, following an evidence review led by University of Birmingham researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2020 Category: International Medicine & Public Health Source Type: news

Inaccurate Risk Perceptions Lead to Worry and Decreased QOL in Patients with Thyroid Cancer
The perceptions, which were associated with worry and a decreased quality of life, indicated the need for patient education that is suitable for diverse populations and improved risk communication by physicians. (Source: CancerNetwork)
Source: CancerNetwork - January 29, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

9/11 Workers May Be at Higher Cancer Risk
Ground zero workers had higher rates of cancer, especially prostate and thyroid cancers and leukemia. (Source: NYT Health)
Source: NYT Health - January 27, 2020 Category: Consumer Health News Authors: Nicholas Bakalar Tags: World Trade Center (Manhattan, NY) Cancer Prostate Cancer Thyroid Cancer Leukemia Mount Sinai Medical Center Source Type: news

Thyroid cancer, genetic variations, and cell phones linked in YSPH Study
People with a certain single nucleotide polymorphism may be at an increased risk of developing thyroid cancer linked to cell phone use, a new study has found. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 27, 2020 Category: Universities & Medical Training Source Type: news

LMR for Prognosis of Radioiodine-Refractory Thyroid Cancer LMR for Prognosis of Radioiodine-Refractory Thyroid Cancer
Find out how the lymphocyte-to-monocyte ratio may aid in the prognosis of patients with progressive radioiodine-refractory differentiated thyroid carcinoma.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2020 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

FDA Approves First Drug For Treatment Of Thyroid Eye Disease
The drug is administered via intravenous therapy (IV), with eight infusions over a six month period. Each infusion can take between an hour to an hour and a half. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 25, 2020 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news

Ultrasound Analysis Framework: Early Step Toward Automated Thyroid Tumor Diagnosis
Evaluation of tumor features as effective as radiologists at distinguishing malignant thyroid nodules (Source: Diagnostic Imaging)
Source: Diagnostic Imaging - January 24, 2020 Category: Radiology Authors: Whitney J. Palmer Tags: Thyroid Cancer Ultrasound Source Type: news

Elastography shows high reproducibility in breast lesions
Two different ultrasound elastography techniques -- strain elastography and...Read more on AuntMinnie.comRelated Reading: Mindray releases new ultrasound system Elastography helps liver transplant patients avoid biopsy Radiofrequency ultrasound, AI predict thyroid cancer Shear-wave elastography tracks effects of knee surgery Elastography methods reduce unnecessary breast biopsies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 24, 2020 Category: Radiology Source Type: news

New Drug Could Help Stop Blindness From Thyroid Eye Disease
It's the first treatment specifically approved for thyroid eye disease. The drug was approved Tuesday by the U.S. Food and Drug Administration. It will be marketed under the brand name Tepezza. (Source: WebMD Health)
Source: WebMD Health - January 23, 2020 Category: Consumer Health News Source Type: news

Teprotumumab Bests Placebo for Active Thyroid Eye Disease
THURSDAY, Jan. 23, 2020 -- Teprotumumab is associated with better outcomes than placebo among patients with active thyroid eye disease, according to a study published in the Jan. 23 issue of the New England Journal of Medicine. Raymond S. Douglas,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 23, 2020 Category: Pharmaceuticals Source Type: news

FDA Approves Teprotumumab (Tepezza) for Thyroid
FDA Approves Teprotumumab (Tepezza) First Treatment for Thyroid Eye Disease (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 23, 2020 Category: General Medicine Source Type: news

New Drug Could Help Stop Blindness From Thyroid Eye Disease
Title: New Drug Could Help Stop Blindness From Thyroid Eye DiseaseCategory: Health NewsCreated: 1/22/2020 12:00:00 AMLast Editorial Review: 1/23/2020 12:00:00 AM (Source: MedicineNet Eyesight General)
Source: MedicineNet Eyesight General - January 23, 2020 Category: Opthalmology Source Type: news

AJR researchers take step toward automating thyroid cancer triage
(American Roentgen Ray Society) An article published ahead-of-print in the April issue of the American Journal of Roentgenology (AJR) details how a Stanford University team developed a quantitative framework able to sonographically differentiate between benign and malignant thyroid nodules at a level comparable to that of expert radiologists, which could provide second-opinion malignancy risk estimation to clinicians and ultimately help decrease the number of unnecessary biopsies and surgical procedures. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 23, 2020 Category: Cancer & Oncology Source Type: news

New Drug Tepezza (teprotumumab) Could Help Stop Blindness From Thyroid Eye Disease
WEDNESDAY, Jan. 22, 2020 -- The newly approved drug teprotumumab can offer hope to adults with thyroid eye disease, a rare and potentially blinding condition. It's the first treatment specifically approved for thyroid eye disease. The drug was... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 22, 2020 Category: General Medicine Source Type: news

FDA Approves First Treatment for Thyroid Eye Disease FDA Approves First Treatment for Thyroid Eye Disease
The monoclonal antibody teprotumumab reduces proptosis and related eye problems in patients with thyroid-associated ophthalmopathy.FDA Approvals (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - January 22, 2020 Category: Endocrinology Tags: Diabetes & Endocrinology News Alert Source Type: news

Horizon's prices thyroid eye disease therapy at $14,900 per vial
Horizon Therapeutics Plc on Tuesday priced its treatment for thyroid eye disease at $14,900 per vial following the U.S. FDA approval and said the drug would be available in the United States in the coming weeks. (Source: Reuters: Health)
Source: Reuters: Health - January 22, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Tepezza (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
DUBLIN--(BUSINESS WIRE)--Jan. 21, 2020-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved Tepezza (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED). Tepezza is the... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - January 21, 2020 Category: Drugs & Pharmacology Source Type: news

Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma Hashimoto Thyroiditis in Primary Thyroid Non-Hodgkin Lymphoma
How prevalent is Hashimoto thyroiditis in cases of primary thyroid lymphoma, and what is its etiology? Is Hashimoto thryoiditis a necessary condition for the development of PTL?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2020 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

FDA approves first treatment for thyroid eye disease
Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis). Today's approval represents the first drug approved for the treatment of thyroid eye disease. (Source: World Pharma News)
Source: World Pharma News - January 21, 2020 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Study Uncovers Drug Combination for Sarcomatoid Mesothelioma
Researchers in Spain have discovered a drug combination showing potential in treating the most difficult-to-treat type of malignant mesothelioma. Selumetinib and AZD8186, already being studied separately in clinical trials for other cancers, displayed efficacy when used in combination on mesothelioma of the sarcomatoid cell type. Researchers at the Spanish National Cancer Research Centre made the discovery during their study using mice models and human tumor cells in the laboratory. “The findings, we hope, are relevant,” Dr. Paco Real, who led the study, told The Mesothelioma Center at Asbestos.com. “We d...
Source: Asbestos and Mesothelioma News - January 16, 2020 Category: Environmental Health Authors: Matt Mauney Source Type: news

Nearly 20 Years Later, Cancer Rates Higher in 9/11 First Responders
This particular group of responders appears to have an increased risk of developing thyroid cancer, leukemia and prostate cancer, as well as a slightly elevated overall risk of cancer, researchers report. (Source: WebMD Health)
Source: WebMD Health - January 14, 2020 Category: Consumer Health News Source Type: news

Cancer Incidence Up in World Trade Center Responder Cohort
Incidence up for all cancer sites combined and for prostate cancer, thyroid cancer, leukemia (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 14, 2020 Category: Cancer & Oncology Tags: Endocrinology, Oncology, Urology, Journal, Source Type: news

Sept. 11 Responders May Be at Heightened Risk of Developing Leukemia
After the Twin Towers fell on Sept. 11, 2001, the thousands of people involved in rescue-and-cleanup efforts were exposed to carcinogens and other toxins as they breathed in contaminated air and dug through industrial rubble. Studies completed since then have shown elevated rates of conditions including multiple myeloma, prostate cancer and thyroid cancer among 9/11 responders and those who worked near the site. A new study published Jan. 14 in the journal JNCI Cancer Spectrum adds another to that list: leukemia. “After about 12 years of follow-up, there was an increase in the rate of all cancers combined, and separa...
Source: TIME: Health - January 14, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Cancer Research Source Type: news

Elevated leukemia incidence is found in World Trade Center rescue and recovery workers
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Responders who worked at the World Trade Center site after the attacks on Sept. 11, 2001, have an increased overall cancer incidence compared to the general population, particularly in thyroid cancer, prostate cancer, and, for the first time ever reported, leukemia, according to a Mount Sinai study published in JNCI Cancer Spectrum in January. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2020 Category: Cancer & Oncology Source Type: news

'Cancer cluster' fears as six residents of street develop tumours
Taylor Wind, 19, is one of 191 people in Mooresville, North Carolina, who were diagnosed with thyroid cancer between 2012 and 2016. which her mother believes is linked to coal ash from a nearby plant. (Source: the Mail online | Health)
Source: the Mail online | Health - January 6, 2020 Category: Consumer Health News Source Type: news

Lilly opens Phase 3 clinical trial in RET-mutant medullary thyroid cancer
Eli Lilly and Company (NYSE: LLY) announced the opening of the LIBRETTO-531 clinical trial [NCT04211337] for selpercatinib, also known as LOXO-292, for treatment-naive RET-mutant medullary thyroid cancer (MTC) patients. This is the second Phase 3 trial to open for selpercatinib, a highly selective and potent, oral investigational new medicine in clinical development for the treatment of patients with cancers that harbor abnormalities in the rearranged during transfection (RET) kinase. (Source: World Pharma News)
Source: World Pharma News - January 3, 2020 Category: Pharmaceuticals Tags: Featured Eli Lilly and Company Business and Industry Source Type: news

Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
LIBRETTO-531 is first ever Phase 3 trial in RET-mutant medullary thyroid cancer Randomized trial will examine selpercatinib against standard of care in 400 patients with advanced or metastatic treatment-naïve RET-mutant medullary thyroid cancer ... Biopharmaceuticals, Oncology Eli Lilly, selpercatinib, RET-mutant, medullary thyroid cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 30, 2019 Category: Pharmaceuticals Source Type: news

Inflammation Linked to Thyroid Dysfunction in Psoriasis Patients
MONDAY, Dec. 30, 2019 -- While the rate of thyroid dysfunction among patients with psoriasis generally is not higher than expected, psoriasis in patients with thyroid dysfunction is more clinically severe and serum levels of C-reactive protein (CRP)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 30, 2019 Category: Pharmaceuticals Source Type: news

UAB establishes new division of breast and endocrine surgery
UAB has established a new surgery division through the Division of Breast and Endocrine Surgery. The new surgery team will provide personalized, comprehensive care for patients with both benign and malignant tumors of the breast, thyroid, parathyroid and adrenal glands.   Dr. Helen Krontiras and endowed professor of surgery, will lead the division as its director. Krontiras also serves as the medical director of the UAB Multidisciplinary Breast Clinic. “I am thrilled with the opportunity to lead… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 27, 2019 Category: Biotechnology Authors: Tyler Patchen Source Type: news

UAB establishes new division of breast and endocrine surgery
UAB has established a new surgery division through the Division of Breast and Endocrine Surgery. The new surgery team will provide personalized, comprehensive care for patients with both benign and malignant tumors of the breast, thyroid, parathyroid and adrenal glands.   Dr. Helen Krontiras and endowed professor of surgery, will lead the division as its director. Krontiras also serves as the medical director of the UAB Multidisciplinary Breast Clinic. “I am thrilled with the opportunity to lead… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 27, 2019 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Obesity and Risk of Differentiated Thyroid Cancer Obesity and Risk of Differentiated Thyroid Cancer
Might obesity contribute to the development of differentiated thyroid cancer? A new study examines the possible relationship.Clinical Endocrinology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 24, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

U.S. Incidence of Thyroid Cancer Plateaued in 2009
TUESDAY, Dec. 24, 2019 -- From 2009 to 2016, the incidence of thyroid cancer reached a plateau and possibly started to decline, according to a research letter published in the Dec. 24/31 issue of the Journal of the American Medical Association. Ann... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 24, 2019 Category: Pharmaceuticals Source Type: news

Does thyroid cancer screening lead to overdiagnosis?
Two studies from the U.S. and South Korea are raising questions about the role...Read more on AuntMinnie.comRelated Reading: CT radiation increases risk of thyroid cancer, leukemia New thyroid test could help patients avoid surgery Radiofrequency ultrasound, AI predict thyroid cancer CT radiomics uses immunohistology to detect thyroid cancer Ultrasound CADx software can stratify thyroid nodules (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 23, 2019 Category: Radiology Source Type: news

Thyroid Cancer Incidence Rates Level Off in US Thyroid Cancer Incidence Rates Level Off in US
After rising steadily for over 30 years, the incidence of thyroid cancer in the United States began to plateau in 2009. It has since remained stable and has now possibly started to decline.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 20, 2019 Category: Cancer & Oncology Tags: Public Health & Prevention News Source Type: news

Thyroid cancer rates in US
(JAMA Network) An   analysis suggests rates of   thyroid cancer in the US appear to have plateaued in recent years after decades on the rise. That increase was mostly attributed to more screening and imaging over the last three decades that detected many small thyroid cancers. Researchers in this observational study used cancer surveillance registry data to examine changes in rates of new cases of thyroid cancer in the US from 1992 to 2016. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 20, 2019 Category: Cancer & Oncology Source Type: news

Tell your patients about this information day on the new thyroid guidelines
The British Thyroid Foundation are holding a patient information day where medical professionals and patients will discuss the latest guidelines on the mangement of thyroid disease. The meeting will take place at The Abbey Centre, 34 Great Smith Street, Westminster, London SW1P 3BU The aim of the meeting is to provide information about the current best practice guidelines for the management of thyroid disorders in so far as they affect adults.In particular speakers will focus on the NICE guidelines which will be published in November 2019. The meeting will not cover thyroid eye disease, pregnancy, thyroid...
Source: Society for Endocrinology - December 17, 2019 Category: Endocrinology Source Type: news

Got a lump in your thyroid? Here's what it means
(Natural News) If you ever find a lump in the thyroid area, don’t start panicking just yet. Those lumps are most likely thyroid nodules. A lot of people develop nodules in their life and never notice them. Most of them are harmless, but some can become cancerous. To properly identify it, consult your trusted healthcare... (Source: NaturalNews.com)
Source: NaturalNews.com - December 16, 2019 Category: Consumer Health News Source Type: news